Serum high-density lipoprotein cholesterol levels as a prognostic indicator in patients with idiopathic pulmonary arterial hypertension

American Journal of Cardiology

Volumn 110, Issue 3, 2012, Pages 433-439

  Zhao, Qin Hua ^a   Peng, Fu Hua ^a   Wei, Hong ^b   He, Jing ^a   Chen, Fa Dong ^a   Di, Ruo Min ^a   Jiang, Xin ^a   Jiang, Rong ^a   Chen, Yan Jun ^b   Heresi, Gustavo A ^c   Jing, Zhi Cheng ^a  

^a TONGJI UNIVERSITY   (China)

^b HARBIN MEDICAL UNIVERSITY   (China)

^c LERNER RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BILIRUBIN; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL; URIC ACID;

ADULT; ARTERIAL CARBON DIOXIDE TENSION; ARTICLE; BILIRUBIN BLOOD LEVEL; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; CORRELATION ANALYSIS; DIAGNOSTIC VALUE; DISEASE SEVERITY; EVENT FREE SURVIVAL; FEMALE; FOLLOW UP; HEART INDEX; HEART RATE; HUMAN; LUNG VASCULAR RESISTANCE; MAJOR CLINICAL STUDY; MALE; PERICARDIAL EFFUSION; PRIORITY JOURNAL; PROGNOSIS; PULMONARY HYPERTENSION; SURVIVAL RATE; TRIACYLGLYCEROL BLOOD LEVEL; URIC ACID BLOOD LEVEL; VENOUS OXYGEN TENSION;

ADULT; ASIAN CONTINENTAL ANCESTRY GROUP; CHOLESTEROL, HDL; FEMALE; HUMANS; HYPERTENSION, PULMONARY; MALE; PROGNOSIS; PROSPECTIVE STUDIES; SEVERITY OF ILLNESS INDEX;

EID: 84863980931     PISSN: 00029149     EISSN: 18791913     Source Type: Journal    
DOI: 10.1016/j.amjcard.2012.03.042     Document Type: Article

References (29)

1. G. Assmann, H. Schulte, A. von Eckardstein, Y. Huang High-density lipoprotein cholesterol as a predictor of coronary heart disease risk: the PROCAM experience and pathophysiological implications for reverse cholesterol transport Atherosclerosis 124 Suppl 1996 S11 S20
2. J.D. Curb, R.D. Abbott, B.L. Rodriguez, K. Masaki, R. Chen, D.S. Sharp, A.R. Tall A prospective study of HDL-C and cholesterol ester transfer protein gene mutations and the risk of coronary heart disease in the elderly J Lipid Res 45 2004 948 953
3. A.R. Sharrett, C.M. Ballantyne, S.A. Coady, G. Heiss, P.D. Sorlie, D. Catellier, W. Patsch Atherosclerosis Risk in Communities Study Group Coronary heart disease prediction from lipoprotein cholesterol levels, triglycerides, lipoprotein(a), apolipoproteins A-I and B, and HDL density subfractions: the Atherosclerosis Risk in Communities (ARIC) study Circulation 104 2001 1108 1113
4. T. Gordon, W.P. Castelli, M.C. Hjortland, W.B. Kannel, T.R. Dawber High density lipoprotein as a protective factor against coronary heart disease: the Framingham study Am J Med 62 1977 707 714
5. R.C. Turner, H. Millns, H.A. Neil, I.M. Stratton, S.E. Manley, D.R. Matthews, R.R. Holman Risk factors for coronary artery disease in non-insulin dependent diabetes mellitus: united kingdom prospective diabetes study (UKPDS: 23) BMJ 316 1998 823 828
6. C.J. Fielding, P.E. Fielding Molecular physiology of reverse cholesterol transport J Lipid Res 36 1995 211 228
7. J.O. Toikka, M. Ahotupa, J.S. Viikari, H. Niinikoski, M. Taskinen, K. Irjala, J.J. Hartiala, O.T. Raitakari Constantly low HDL-cholesterol concentration relates to endothelial dysfunction and increased in vivo LDL-oxidation in healthy young men Atherosclerosis 147 1999 133 138
8. B.J. Ansell, M. Navab, S. Hama, N. Kamranpour, G. Fonarow, G. Hough, S. Rahmani, R. Mottahedeh, R. Dave, S.T. Reddy, A.M. Fogelman Inflammatory/ antiinflammatory properties of high-density lipoprotein distinguish patients from control subjects better than high-density lipoprotein cholesterol levels and are favorably affected by simvastatin treatment Circulation 108 2003 2751 2756
9. A.M. Zeiher, V. Schächlinger, S.H. Hohnloser, B. Saurbier, H. Just Coronary atherosclerotic wall thickening and vascular reactivity in humans: elevated high-density lipoprotein levels ameliorate abnormal vasoconstriction in early atherosclerosis Circulation 89 1994 2525 2532
10. J.H. Griffin, K. Kojima, C.L. Banka, L.K. Curtiss, J.A. Fernández High-density lipoprotein enhancement of anticoagulant activities of plasma protein S and activated protein C J Clin Invest 103 1999 219 227
11. 2 half-life regulated by high density lipoprotein is decreased in acute myocardial infarction and unstable angina pectoris Circulation 81 1990 1784 1791
12. G.A. Heresi, M. Aytekin, J. Newman, J. DiDonato, R.A. Dweik Plasma levels of high-density lipoprotein cholesterol and outcomes in pulmonary arterial hypertension Am J Respir Crit Care Med 182 2010 661 668
13. D.B. Badesch, G.E. Raskob, C.G. Elliott, A.M. Krichman, H.W. Farber, A.E. Frost, R.J. Barst, R.L. Benza, T.G. Liou, M. Turner, S. Giles, K. Feldkircher, D.P. Miller, M.D. McGoon Pulmonary arterial hypertension: baseline characteristics from the REVEAL registry Chest 137 2010 376 387
14. R. Zhang, L.Z. Dai, W.P. Xie, Z.X. Yu, B.X. Wu, L. Pan, P. Yuan, X. Jiang, J. He, M. Humbert, Z.C. Jing Survival of Chinese patients with pulmonary arterial hypertension in the modern treatment era Chest 140 2011 301 309
15. G. Simonneau, I.M. Robbins, M. Beghetti, R.N. Channick, M. Delcroix, C.P. Denton, C.G. Elliott, S.P. Gaine, M.T. Gladwin, Z.C. Jing, M.J. Krowka, D. Langleben, N. Nakanishi, R. Souza Updated clinical classification of pulmonary hypertension J Am Coll Cardiol 54 1 Suppl 2009 S43 S54
16. W.T. Friedewald, R.I. Levy, D.S. Fredrickson Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge Clin Chem 18 1972 499 502
17. G.E. D'Alonzo, R.J. Barst, S.M. Ayres, E.H. Bergofsky, B.H. Brundage, K.M. Detre, A.P. Fishman, R.M. Goldring, B.M. Groves, J.T. Kernis, P.S. Levy, G.G. Pietra, L.M. Reid, J.T. Reeves, S. Rich, C.E. Vreim, G.W. Williams, M. Wu Survival in patients with primary pulmonary hypertension Results from a national prospective registry Ann Intern Med 115 1991 343 349
18. S. Miyamoto, N. Nagaya, T. Satoh, S. Kyotani, F. Sakamaki, M. Fujita, N. Nakanishi, K. Miyatake Clinical correlates and prognostic significance of six-minute walk test in patients with primary pulmonary hypertension: comparison with cardiopulmonary exercise testing Am J Respir Crit Care Med 161 2000 487 492
19. N. Nagaya, M. Uematsu, T. Satoh, S. Kyotani, F. Sakamaki, N. Nakanishi, M. Yamagishi, T. Kunieda, K. Miyatake Serum uric acid levels correlate with the severity and the mortality of primary pulmonary hypertension Am J Respir Crit Care Med 160 1999 487 492
20. M.M. Hoeper, M.W. Pletz, H. Golpon, T. Welte Prognostic value of blood gas analyses in patients with idiopathic pulmonary arterial hypertension Eur Respir J 29 2007 944 950
21. R.J. Raymond, A.L. Hinderliter, P.W. Willis, D. Ralph, E.J. Caldwell, W. Williams, N.A. Ettinger, N.S. Hill, W.R. Summer, B. de Boisblanc, T. Schwartz, G. Koch, L.M. Clayton, M.M. Jöbsis, J.W. Crow, W. Long Echocardiographic predictors of adverse outcomes in primary pulmonary hypertension J Am Coll Cardiol 39 2002 1214 1219
22. V.V. McLaughlin, A. Shillington, S. Rich Survival in primary pulmonary hypertension: the impact of epoprostenol therapy Circulation 106 2002 1477 1482
23. M. Humbert, O. Sitbon, A. Chaouat, M. Bertocchi, G. Habib, V. Gressin, A. Yaïci, E. Weitzenblum, J.F. Cordier, F. Chabot, C. Dromer, C. Pison, M. Reynaud-Gaubert, A. Haloun, M. Laurent, E. Hachulla, V. Cottin, B. Degano, X. Jaïs, D. Montani, R. Souza, G. Simonneau Survival in patients with idiopathic, familial, and anorexigen-associated pulmonary arterial hypertension in the modern management era Circulation 122 2010 156 163
24. R.T. Zamanian, G. Hansmann, S. Snook, D. Lilienfeld, K.M. Rappaport, G.M. Reaven, M. Rabinovitch, R.L. Doyle Insulin resistance in pulmonary arterial hypertension Eur Respir J 33 2009 318 324
25. J. He, D.F. Gu, K. Reynolds, X.G. Wu, P. Muntner, J.G. Zhao, J. Chen, D.H. Liu, J.P. Mo, P.K. Whelton InterASIA Collaborative Group Serum total and lipoprotein cholesterol levels and awareness, treatment, and control of hypercholesterolemia in China Circulation 110 2004 405 411
26. J.B. Christian, N.E. Bourqeois, K.A. Lowe Prevalence, clinical characteristics and treatment patterns of low high-density lipoprotein cholesterol in the US population: national health and nutrition examination survey 2005-2008 J Cardiovasc Med 12 2011 714 722
27. M. Humbert, G. Monti, F. Brenot, O. Sitbon, A. Portier, L. Grangeot-Keros, P. Duroux, P. Galanaud, G. Simonneau, D. Emilie Increased interleukin-1 and interleukin-6 serum concentrations in severe primary pulmonary hypertension Am J Respir Crit Care Med 151 1995 1628 1631
28. R. Quarck, T. Nawrot, B. Meyns, M. Delcroix C-reactive protein: a new predictor of adverse outcome in pulmonary arterial hypertension J Am Coll Cardiol 53 2009 1211 1218
29. E. Soon, A.M. Holmes, C.M. Treacy, N.J. Doughty, L. Southgate, R.D. Machado, R.C. Trembath, S. Jennings, L. Barker, P. Nicklin, C. Walker, D.C. Budd, J. Pepke-Zaba, N.W. Morrell Elevated levels of inflammatory cytokines predict survival in idiopathic and familial pulmonary arterial hypertension Circulation 122 2010 920 927